Bharat Rawlley

Bharat Rawlley

Auto-generated profile, based on publicly available information

Bharat Rawlley

University of Vermont

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in Stroke
Verified
Journal Article
Closed access
PDF file
BRBharat Rawlley
Bharat Rawlley
SMSarah Marchina
Sarah Marchina
SCStefanie P. Cappucci
Stefanie P. Cappucci
BGBhanu Gogia
Bhanu Gogia
JWJia-Yi Wang
Jia-Yi Wang
SKSandeep Kumar
Sandeep Kumar
Background: Gender disparities among principal investigators of clinical trials (CT) can have implications regarding the areas of investigation, methods, conduct, trial enrollment, and interpretation of results. An estimation of the gender gap in the leadership of stroke-related CTs from North America has to date not been undertaken. Methods: We extracted information about stroke-related CTs between 2011 and 2020 from www.Clinicaltrials.gov and PubMed. We examined the gender distribution according to the academic credentials and the trial type. The gender of PIs and authors was determined using gender package in R, which identifies gender using historical data from the United States. Additionally, we obtained information from Association of American Medical Colleges and the Accreditation Council for Graduate Medical Education data resource books on the gender composition of full-time neurology faculty, neurology residents and vascular neurology fellows. Results: In these analyses of 821 CTs registered on Clinicaltrials.gov and 110 trials published on PubMed, we found that gender disparity among the PIs, first and last authors have persisted over the last decade without any significant trend toward parity ( P >0.05). On examining the gender distribution according to academic credentials and trial type, we found that men were over-represented in the sub-group of PIs with an MD degree (78.11% versus 21.87%; P <0.01) and those leading acute stroke trials (86.04% versus 13.89%; P <0.01). We also found that a lower proportion of women neurology residents pursued a vascular neurology fellowship during this period (33.5% versus 42.5%; P <0.05). Conclusions: Our results show that the favorable trend toward gender parity seen in Neurology faculty over the last decade has not translated to the same in the leadership of CTs. Our findings merit further investigation and a re-examination of efforts toward inclusion of women as leaders of stroke-related CTs.

5 April 2024 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
BRBharat Rawlley
Bharat Rawlley
KGKartik Gupta
Kartik Gupta
SKSubaina Naeem Khalid
Subaina Naeem Khalid
PVPratyaksh P. Vaishnav
Pratyaksh P. Vaishnav
ASAndres Cordova Sanchez
Andres Cordova Sanchez
DCDebanik Chaudhuri
Debanik Chaudhuri

1 January 2024 in Journal of Investigative Medicine High Impact Case Reports
Verified
Journal Article
Open access
BRBharat Rawlley
Bharat Rawlley
PVPratyaksh P. Vaishnav
Pratyaksh P. Vaishnav
SKSubaina Naeem Khalid
Subaina Naeem Khalid
SPShweta Paulraj
Shweta Paulraj
ZEZiad A. El-Khally
Ziad A. El-Khally
JAJamal Ahmed
Jamal Ahmed
We illustrate the case of a 62-year-old man with a symptomatic anomalous right coronary artery from pulmonary artery (ARCAPA). Our patient had presented with dyspnea on exertion with electrocardiogram showing pronounced inferior Q waves and marked inferolateral ST-T wave changes. The patient had a nuclear stress test which showed inferior wall ischemia. Subsequently, the patient underwent coronary angiography which showed an ARCAPA. The patient underwent surgical repair with reimplantation of the right coronary artery to the ascending aorta which was tolerated well. Our case illustrates ARCAPA presenting late in adulthood with ischemic symptoms that was treated with corrective surgery.

20 October 2023 in The American Journal of Cardiology
Verified
Journal Article
Closed access
BRBharat Rawlley
Bharat Rawlley
ASAndres Cordova Sanchez
Andres Cordova Sanchez
KGKartik Gupta
Kartik Gupta
MRMatthew Ramm
Matthew Ramm
DCDebanik Chaudhuri
Debanik Chaudhuri

18 November 2020 in Pharmacogenomics
Verified
Journal Article
Closed access
BRBharat Rawlley
Bharat Rawlley
ODOsama Diab
Osama Diab
RARaed Al-Rajabi
Raed Al-Rajabi
ECErin Carroll
Erin Carroll
TMTina Melancon
Tina Melancon
AKAnup Kasi
Anup Kasi

14 July 2025 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Open access
KGKartik Gupta
Kartik Gupta
MQMuhammad Ahmad Qureshi
Muhammad Ahmad Qureshi
BRBharat Rawlley
Bharat Rawlley
VJVardhmaan Jain
Vardhmaan Jain
AVAtul Verma
Atul Verma
MRMohamad Raad
Mohamad Raad
Introduction: Intramyocardial needle ablation is a novel technique for treating refractory ventricular tachycardia (VT) and premature ventricular complexes (PVC). However, studies defining the effectiveness and safety of this procedure are limited. This meta‐analysis aims to evaluate the safety and effectiveness of needle ablation for VT and PVC refractory to standard ablation.Methods: Embase, Ovid (includes Medline), and ClinicalTrials.gov were searched from inception to December 31, 2024. Human studies on needle ablation for recurrent VT and PVC were included. Primary outcome was immediate effectiveness (no immediate post‐procedural inducible VT or PVC). Secondary outcomes were long‐term effectiveness (no clinical VT or PVC at 6 months) and safety (composite measure of peri‐ and post‐procedural complications).Results: A total of five studies including 180 patients (140 VT; 40 PVC) were analyzed. Mean ages ranged from 54 to 66 years. Among 129 patients with VT, immediate effectiveness was 75% (95% CI, 54–92; I2 80%), and cumulative freedom from clinical VT dropped to 43% at 6 months (95% CI, 35–52; I2 0%). Among 40 patients with PVC, immediate effectiveness was 82% (95% CI, 67–94; I2 0%), and long‐term effectiveness was 76% (95% CI, 61–90; I2 0%). Safety outcomes were reported in 19% of patients (95% CI, 13–27; I2 0%) and 10% of patients (95% CI 1, 23; I2 0%) in the VT and PVC arm, respectively. Death related to ablation was report in 7 patients (5.0%) only in the VT studies.Conclusion: Intramyocardial needle ablation is an emerging alternative approach for refractory VT and PVC ablation, showing cautious but promising results and safety profiles. Prospective studies and an international registry could provide valuable insights needed for optimal patient selection and protocol refinement.